Logo image
A low-energy emulsification platform based on a Diet Coke–Mentos reaction-derived bubbly flow for formulating various emulsions as drug carriers
期刊文章   同儕審查

A low-energy emulsification platform based on a Diet Coke–Mentos reaction-derived bubbly flow for formulating various emulsions as drug carriers

Yu-Jung Lin, Po-Kai Luo, Huei-Rou Su, Hung-Yun Lu, Wan-An Chang, Min-Chun Chiang, Hsin-Lung Chen, Kai Chen, Hao-Ji Wei, Kun-Ju Lin, …
Biomaterials, 卷.301, 122264
10/2023
PMID: 37562155

摘要

Drug delivery Emulsion Henry's law Nucleation theory U-tube reactor Biophysics Bioengineering Ceramics and Composites Biomaterials Mechanics of Materials
The formulation of a drug using high-energy emulsification commonly causes drug deterioration. Exploiting the well-known Diet Coke–Mentos reaction (DCMR), a U-shaped tube reactor that can generate an eruption of bubbly flow that can serve as a low-energy emulsification platform, is proposed. The liquid in the U-tube reactor is a supersaturated solution of aqueous CO 2 , which mimics Diet Coke. When glass beads with rough surfaces, mimicking Mentos, are dropped into the carbonated water, an eruptive bubbly flow is spontaneously created, mediating effective emulsification at a compound water–oil interface. Experimental results demonstrate that DCMR-mediated bubbly flow may provide a versatile platform for the production of “oil-in-water” or “water-in-oil” droplets and Pickering emulsion composite particles as drug carriers. The DCMR-derived bubbly flow is generated without significant temperature elevation, so the activity of the drug to be emulsified is unaffected. In vivo results reveal the feasibility of using this low-energy emulsification platform to formulate an emulsion system that contains catalase, a temperature-sensitive oxidoreductase, to mitigate an experimentally formed paw inflammation in mice. The as-proposed emulsification platform is attractive for formulating numerous drug delivery systems on a small-scale in a customized manner to meet the needs of each individual for personalized medicine.

相關連結

指標

1 檢視次數

詳細資料

Logo image